Tropical Journal of Pharmaceutical Research Pharmacotherapy Group, Faculty of Pharmacy, University of Benin, Benin City, Nigeria ISSN: 1596-5996 EISSN: 1596-9827 Vol. 6, Num. 3, 2007, pp. 755-765

Tropical Journal of Pharmaceutical Research, Vol. 6, No. 3, September 2007, pp. 755-765

Research Article

Evaluation of hepatoprotective and antioxidant activity of Ichnocarpus frutescens (Linn.) R.Br. on paracetamol-induced hepatotoxicity in rats

Deepak K. Dash^{1, 2}, Veerendra C. Yeligar ², Siva S. Nayak², Tirtha Ghosh³, D. Rajalingam ², Pinaki Sengupta ², Bhim C. Maiti ², Tapan K. Maity ^2*.

¹College of Pharmaceutical Sciences, Mohuda, Berhampur, Orissa, India.
²Division of Pharmaceutical Chemistry, Department of Pharmaceutical Technology, Jadavpur University, Kolkata700032, India. ³Institute of Pharmacy and Technology, Salipur, Orissa-754202, India
*Corresponding Author: Tel: +913324146074 E-mail: jutkmaity@yahoo.com

Code Number: pr07017

Abstract

Purpose: The entire plant including the flowers, of Ichnocarpus frutescens R.Br. (Apocynaceae) has been used for the treatment of cancer, skin infections, diabetes and liver disorder. The present study is aimed at evaluating the hepatoprotective effect of chloroform and methanol extract (CEIF and MEIF) of whole plant of I. frutescens (Linn.) by paracetamol-induced liver damage in rats.
Methods: The chloroform and methanolic extracts of I. frutescens (CEIF and MEIF) were studied for their hepatoprotective and antioxidant effects on paracetamol (750mg/kg) induced acute liver damage on Wistar albino rats. The degree of protection was measured by using biochemical parameters such as serum glutamate oxalate transaminase (SGOT) and serum glutamate pyruvate transaminase (SGPT), alkaline phosphatase (ALP), bilirubin and total protein. Further, the effects of both extracts on lipid peroxidation (LPO), glutathione (GSH), superoxide dismutase (SOD) and catalase (CAT) were estimated.
Results: CEIF and MEIF at a dose level of 250mg/kg and 500mg/kg produce significant (P<0.05) hepatoprotection by decreasing the activity of serum enzymes, bilirubin, and lipid peroxidation, while they significantly increased the levels of Glutathione (GSH), superoxide dismutase (SOD) and catalase (CAT) in a dose dependent manner. The effects of CEIF and MEIF were comparable to that of standard drug, Silymarin.
Conclusion: From this study, it can be concluded that the chloroform and methanol extract of I. frutescens is not only an effective hepatoprotective agent, but also possesses significant (p<0.05) antioxidant activity.

Keywords: Ichnocarpus frutescens, Hepatoprotective effect, Antioxidant role, Paracetamol.

INTRODUCTION

Aerobic organs such as the liver generate reactive oxygen species that induce oxidative tissue damage. These radicals, which react with cell membranes and thus induce lipid peroxidation or cause inflammation, have been implicated as important pathological mediators in many clinical disorders such as heart disease, diabetes, gout and cancer ^1-3. A major defence mechanism is the antioxidant enzymes, which convert active oxygen molecules into non-toxic compounds ^{4, 5} .

Liver diseases remain as one of the serious health problems. However we do not have satisfactory liver protective drugs in allopathic medical practice for serious liver disorders. Herbal drugs play a role in the management of various liver disorders most of which speed up the natural healing processes of the liver. Numerous medicinal plants and their formulations are used for liver disorders in ethnomedical practice as well as traditional system of medicine in India. More than fifteen of these plants are evaluated for their hepatoprotective action in light of modern medicine ⁶.

The plant Ichnocarpus frutesecens (linn). R.Br. (Family: Apocynaceae) is a large much branched twining shrub; young branches finely fulvous-tomentose. Leaves 4.5-7.5 by 2-3.8 cm, elliptic-oblong, acute or acuminate, glabrous above, glabrous or slightly pubescent and pale beneath, base usually rounded, occasionally found in village surroundings and hedges throughout India⁷. It is locally called Botilai and the plant is used by the local peoples of Mohuda, Berhampur, Orissa, India for simple fevers and to treat liver disorder. The whole plant is used as a tribal medicine in atrophy, bleeding gums, cough and dysentery ⁸. Stalk and leaves in decoction is used in the treatment of skin eruptions. A decoction of the roots of Colocynth, Anantamul, Sariva (Sanskrit) and Hedyotis biflora prepared in the usual way is administered with the addition of powdered long pepper and bdellium in chronic skin diseases, syphilis, loss of sensation and hemiplegia ⁹. Silymarin is a flavonolignan that has been introduced fairly recently as a hepatoprotective agent. Silymarin is extracted from the seeds and fruits of Silybum marianum and in reality is a mixture of three structural components: Silibinin, Silydianine and Silychristine.

Clinical trials have shown that Silymarin exerts hepatoprotective effects in acute viral hepatitis, poisoning by Amanita phalloides, ethanol, paracetamol, and carbon tetrachloride. Many studies have demonstrated the beneficial hepatoprotective effects when treatment with Silymarin ¹⁰.

However, no work has been reported on the hepatoprotective properties of this plant. Keeping this in view, the present study has been undertaken to investigate hepatoprotective activity and antioxidant role of the chloroform and methanol extract (CEIF & MEIF) of Ichnocarpus frutescens (Linn) on paracetamol induced liver damage in rats.

The plant Ichnocarpus frutescens (Family: Apocynaceae) was collected from Mohuda forest area, Ganjam district, Berhampur, Orissa, India in the month of September. The plant material was taxonomically identified by the taxonomists of Botanical Survey of India, Kolkata. A voucher specimen (NO.CNH/I-I (98)/2005/Tech.II/1448) has been preserved in our laboratory for future reference.

The whole plant was dried under shade and then powered with a mechanical grinder to obtain a coarse powder, which was then subjected to successive extraction in a Soxhlet apparatus using petroleum ether (60-80 ⁰C), chloroform and methanol. Solvent elimination under reduced pressure afforded the chloroform extract (2 % w/w yield) and methanol extract (17 % w/w yield) respectively. The resulting chloroform and methanol extracts were then used for hepatoprotective and in vivo antioxidant studies.

Studies were carried out using male Wistar albino rats (150-200g). They were obtained from the animal house, Indian Institute of Chemical Biology (IICB), Kolkata, India. The animals were grouped and housed in polyacrylic cages (38 x 23 x10 cm) with not more than six animals per cage and maintained under standard laboratory conditions (temperature 25 ± 2⁰C) with dark and light cycle (12/12 h). The animals were fed with standard pellet diet supplied by Hindustan Lever Ltd., Kolkata, India and fresh water ad libitum. All the animals were acclimatized to laboratory condition for a week before commencement of experiment. All procedures described were reviewed and approved by the University Animals Ethical Committee.

Silymarin was purchased from Micro labs, Tamilnadu. India SGOT, SGPT, ALP, Bilirubin and Total Protein kits were procured from Span Diagnostics, Surat, India. Thiobarbituric acid (TBA), Nitro blue tetrazolium chloride (NBT), Phenazine methosulphate were purchased from Central Drug House, New Delhi, India and 5,5'dithiobis-2-nitrobenzoic acid (DTNB), Reduced Glutathione (GSH) and the rest of the chemicals utilized were of analytical grade and were obtained from Sisco research laboratories, Mumbai, India.

Animals were randomized and divided into seven groups (I-VII) of six animals in each group. Group I served as untreated control and fed orally with normal saline 5ml/kg body weight daily for seven days. Group II rats were similarly treated as group I. Group III and IV were treated with 250mg and 500mg/kg body weight of the chloroform extract and Group V and VI were treated with the methanolic extract orally daily for seven days respectively ¹¹. Animals of Group VII were fed with standard drug Silymarin 25mg/kg¹²; p.o daily for seven days.

On the seventh day, paracetamol suspension was given by oral route, in a dose of 750mg/kg body weight to all rats except the rats in group I .The biochemical parameters were estimated after an 18h fast following the last dose.

Biochemical studies

The blood was obtained from all animals by puncturing retro-orbital plexus. The blood samples were allowed to clot for 45 min at room temperature. Serum was separated by centrifugation at 2500rpm at 30⁰C for 15 min and utilized for the estimation of various biochemical parameters namely SGOT, SGPT ¹³, SALP¹⁴, serum bilirubin¹⁵ and total protein ¹⁶.

After collection of blood samples the rats in different groups were sacrificed and their livers were excised immediately and washed in ice cold normal saline, followed by 0.15 M Tris-Hcl (pH 7.4) blotted dry and weighed. A 10%w/v of homogenate was prepared in 0.15 M Tris-Hcl buffer and processed for the estimation of lipid peroxidation¹⁷. A part of homogenate after precipitating proteins with Trichloroacetic acid (TCA) was used for estimation of glutathione¹⁸. The rest of the homogenate was centrifuged at 1500 rpm for 15 min at 4⁰ C. The supernatant thus obtained was used for estimation of SOD and CAT activities^{19, 20}.

Activities of serum glutamate oxaloacetate transaminase (SGOT) and serum glutamate pyruvate transaminase (SGPT) were estimated by the method of Reitman and Frankel¹³. 0.05 ml of serum with 0.25 ml of substrate (aspartate and α-ketoglutarate for SGOT; alanine and α keto glutarate for SGPT, in phosphate buffer pH 7.4) was incubated for an hour in case of SGOT and 30 min. for SGPT. 0.25 ml of DNPH solution was added to arrest the reaction and kept for 20 min in room temperature. After incubation 1 ml of 0.4N NaOH was added and absorbance was read at 505 nm in uv-vis spectrophotometer. Activities were expressed as IU/L.

Based on the method of King and Armstrong¹⁴ alkaline phosphatase activity was assayed using disodium phenyl phosphate as substrate. The made up to 4ml with distilled water and then colour developed was read at 510 nm in uv-vis heated at 95⁰C in a water bath for 60 min. After spectrophotometer after 10 min. Activities of ALP incubation the tubes were cooled to room was expressed as IU/L. Serum total bilirubin temperature and the final volume was made upto level was estimated based on the method of 5 ml in each tube. Then 5 ml of n-butanol:

Malloy and Evelyn¹⁵. Diazotised sulphonilic acid (0.25 ml) reacts with bilirubin in diluted serum were vortexed thoroughly for 2 min. After (0.1 ml serum + 0.9 ml distilled water) and forms centrifugation at 3000 rpm for 10 min the upper purple colored azobilirubin, which was measured organic layer was taken and its OD was read at at 540 nm in uv-vis spectrophotometer. Activities 532 nm against an appropriate blank without the of total bilirubin were expressed as mg/dl. Serum sample. The levels of lipid peroxides were total protein level was estimated based on the expressed as milimoles of thiobarbituric acid method of Gornall et al¹⁶. Biuret reagent (1.0 ml) reactive substances (TBARS)/100gram of liver reacts with serum (10 µL) and the colour tissue using an extinction co-efficient of 1.56x10 developed was read at 578 nm in uv-vis ⁵M^-1cm^-1. spectrophotometer. Activities of total protein was expressed as mg/dl.

Determination of reduced glutathione (GSH)

Reduced glutathione (GSH) was determined by the method of Ellman18. To 0.1 ml of different tissue homogenate 2.4 ml of 0.02M EDTA solution was added and kept on ice bath for 10 min. Then 2 ml of distilled water and 0.5 ml of 50 % TCA were added. This mixture was kept on ice for 10-15 min and then centrifuged at 3000 rpm for 15 min. 1 ml of supernatant was taken and 2ml of Tris-Hcl buffer was added. Then 0.05 ml of DTNB solution (Ellman’s reagent) was added and vortexed thoroughly. OD was read (within 2-3min after the addition of DTNB) at 412 nm against a reagent blank. Absorbance values were compared with a standard curve generated from known GSH.

Assay of super oxide dismutase (SOD)

Superoxide dismutase (SOD) activity was determined by the method of Kakkar et al¹⁹. The assay mixture contained 0.1ml of sample, 1.2ml of sodium pyrophosphate buffer (pH 8.3, 0.052 M), 0.1 ml of phenazine methosulphate (186µm), 0.3 ml of nitro blue tetrazolium (300µm), 0.2 ml of NADH (750 µm). Reaction was started by addition of NADH. After incubation at 30⁰ C for 90 sec, the reaction was stopped by the addition of 0.1 ml of glacial acetic acid. The reaction mixture was stirred vigorously with 4.0 ml of nbutanol. The mixture was allowed to stand for 10 min, centrifuged and butanol layer was separated. The colour intensity of the chromogen in butanol layer was measured at 560 nm against n-butanol and concentration of SOD was expressed as units/g of liver tissue. Absorbance values were compared with standard curve generated from known SOD.

Catalase was assayed according to the method of Aebi²⁰. The estimation was done spectrophotometrically following the decrease in absorbance at 230 nm. The liver tissue was homogenized in M/150 phosphate buffer (pH 7.0) at 1-4⁰ C and centrifuged at 5000 rpm. The reaction mixture contained 0.01 M phosphate buffer (pH 7.0), 2 mM H2O2 and the enzyme extract. The specific activity of catalase was expressed in terms of units/gram of liver tissue. Absorbance values were compared with standard curve generated from known CAT.

Small pieces of liver tissues in each group were collected in 10% neutral buffered formalin for proper fixation. These tissues were processed and embedded in paraffin wax. Sections of 56µm in thickness were cut and stained with hematoxylin and eosin (H&E). These sections were examined photo microscopically for necrosis, steatosis and fatty changes of hepatic cells.

The experimental results were expressed as the Mean ± SEM for six animals in each group. The biochemical parameters were analysed statistically using one-way analysis of variance ANOVA, followed by Dunnett’s mutiple comparison test (DMCT). P value of < 0.05 was considered as statistically significant.

The effects of CEIF and MEIF on serum transaminase, alkaline phosphatase, bilirubin and total protein levels in paracetamol-induced liver damage in rats are summarized in Table-1. Administration of paracetamol (750mg/kg; body weight), after 18 hours of intoxication resulted a significant (P<0.05) elevation of hepatospecific serum markers SGOT, SGPT, SALP, bilirubin and total protein in paracetamol-treated group, in comparison with the normal control group. On administration of CEIF and MEIF (Group III to VI, Table-1) and Silymarin at the dose of 25mg/kg a (Group VII, Table-1) the level of these enzymes were found retrieving towards normalcy.

The effects of CEIF and MEIF on rat liver lipid peroxidation, glutathione and enzymic antioxidants namely SOD and CAT levels are shown in Fig. 1, 2, 3, 4. The levels of TBARS were considerably increased in rats treated with paracetamol as compared to the normal rats. Treatment with CEIF and MEIF (250 mg and 500 mg/kg/day) resulted in a significant decrease (P<0.05) in levels of TBARS and brought them near to normal level (Fig. 1). A significant decrease in the activities of glutathione and a enzymic antioxidants (SOD and CAT) were noted after single administration of paracetamol. Upon administration of CEIF and MEIF, the activities of glutathione and enzymic antioxidants were significantly (P<0.05) reversed to near normal (Fig. 2, 3, 4). The effects of CEIF and MEIF were comparable with that of standard reference drug Silymarin.

Histopathological studies of rat liver tissue from Group I animals show normal hepatic cells with central vein (V) and sinusoidal dilation (Fig. 5). In paracetamol treated group (Group II), severe hepatotoxicity was observed by severe necrosis (N) with disappearance of nuclei (Fig. 6). Mild degree of necorsis (N) with normal cells (C) was observed in Group III and mild degree of necrosis (N) with areas of inflammation adjacent to necrosised area was observed in Group V animals, treated with CEIF and MEIF (250mg/kg/day) respectively (Fig. 7, 8, 9) while normal hepatocytes with regenerating hepatocytes and mild inflammation in the portal area (M) was observed with Group IV and normal hepatocytes with mild inflammation of portal tried (M) was observed with group VI animals at the dose of 500mg/kg/day of CEIF and MEIF respectively (Fig. 8, 9, 10). The liver taken from Group VII animals treated with standard drug Silymarin showed the normal hepatic cells with portal vein (V) and portal artery (Fig. 11).

Paracetamol (acetaminophen) is a commonly and widely used analgesic and antipyretic agent. Hepatotoxic doses of acetaminophen deplete the normal levels of hepatic glutathione, when NAPQI covalently binds to cysteine groups on proteins to form 3-(cystein-S-yl) acetaminophen adducts²¹. The glutathione protects hepatocytes by combining with the reactive metabolite of paracetamol thus preventing their covalent binding to liver proteins ²².

In living systems, liver is considered to be highly sensitive to toxic agents. The study of different enzyme activities such as SGOT, SGPT, SALP, total bilirubin and total protein have been found to be of great value in the assessment of clinical and experimental liver damage ²³. In the present investigation it was observed that the animals treated with acetaminophen resulted in significant hepatic damage as shown by the elevated levels of serum markers. These changes in the marker levels will reflect in hepatic structural integrity. The rise in the SGOT is usually accompanied by an elevation in the levels of SGPT, which play a vital role in the conversion of amino acids to keto acids²⁴. The pretreatment with CEIF and MEIF, both at the dose of 250mg/kg and 500mg/kg, significantly attenuated the elevated levels of the serum markers. The normalization of serum markers by CEIF and MEIF suggests that they are able to condition the hepatocytes so as to protect the membrane integrity against acetaminopheninduced leakage of marker enzymes into the circulation. The above changes can be considered as an expression of the functional improvement of hepatocytes, which may be caused by an accelerated regeneration of parenchyma cells. Serum ALP and bilirubin levels, on the other hand are related to hepatic cell damage. Increase in serum level of ALP is due to increased synthesis in presence of increasing billiary pressure²⁵. Effective control of bilirubin level and alkaline phosphatase activity points towards an early improvement in the secretory mechanism of the hepatic cell.

Lipid peroxidation has been postulated to the destructive process of liver injury due to acetaminophen administration. In the present study the elevations in the levels of end products of lipid peroxidation in the liver of rat treated with paracetamol were observed. The increase in malondialdehyde (MDA) levels in liver suggests enhanced lipid peroxidation leading to tissue damage and failure of antioxidant defense mechanisms to prevent formation of excessive free radicals. Treatment with CEIF and MEIF significantly reversed these changes. Hence it may be possible that the mechanism of hepatoprotection by CEIF and MEIF is due to its antioxidant effect.

The non-enzymic antioxidant, glutathione is one of the most abundant tripeptides present in the liver. Its functions are mainly concerned with the removal of free radical species such as hydrogen peroxide, superoxide radicals, alkoxy radicals, and maintenance of membrane protein thiols and as a substrate for glutathione peroxidase and GST ²⁶. In our present study the decreased level of GSH has been associated with an enhanced lipid peroxidation in paracetamol-treated rats. Administration of CEIF and MEIF significantly increased the level of glutathione in a dose-dependent manner.

The enzymic antioxidant defense system is the nature protector against lipid peroxidation. SOD, CAT and GPx enzymes are important scavengers of superoxide ion and hydrogen peroxide. These enzymes prevent generation of hydroxyl radical and protect the cellular constituents from oxidative damage ²⁷. In the present study, it was observed that the CEIF and MEIF significantly increased the hepatic SOD activity in paracetamol induced liver damage in rats. This show CEIF and MEIF can reduce reactive free radicals that might lessen oxidative damage to the tissues and improve the activities of the hepatic antioxidant enzyme.

Catalase (CAT) is an enzymatic antioxidant widely distributed in all animal tissues and the highest activity is found in the red cells and in the liver. CAT decomposes hydrogen peroxide and protects the tissue from highly reactive hydroxyl radicals²⁸. Therefore the reduction in the activity of these enzymes may result in a number of deleterious effects due to the accumulation of superoxide radicals and hydrogen peroxide. Administration of CEIF and MEIF increased the activities of CAT in paracetamol-induced liver damage in rats to prevent the accumulation of excessive free radicals and protected the liver from paracetamol intoxication.

The histopathological observations in paracetamol-treated rats showed severe necrosis, with disappearnce of nuclei. This could be due to the formation of highly reactive radicals because of oxidative threat caused by paracetamol. All these changes were very much reduced histopathologically in rats treated with CEIF and MEIF. Based on the above results, it could be concluded that CEIF and MEIF exerts significant hepatoprotection against paracetamol-induced toxicity.

The present investigation indicates that CEIF and MEIF exert significant protection against paracetamol-induced toxicity by its ability to ameliorate the lipid peroxidation through the free radicals scavenging activity, which enhanced the levels of antioxidant defense system. Our study also showed that MEIF in the dose of 250mg/kg and 500mg/kg has greater effect than CEIF at the same dose level. Therefore MEIF appears to be useful in the attenuation of paracetamolinduced lipid peroxidation and showed more prominent effect than CEIF. Both the extract showed significant activity against paracetamol induced liver damage in rats when compared with that of standard drug silymarin. Further investigation is underway to determine the exact phytoconstituents in the extracts that are responsible for its hepatoprotective effect.

One of the authors Deepak Kumar Dash, Senior Research Fellow is grateful to the authority of College of Pharmaceutical Sciences, Mohuda, Berhampur, Orissa for sanctioning study leave and the authority of Jadavpur University for providing all facilities.

1. Slater TF. Free-radical mechanism in tissue injury. Biochem J 1984; 222: 1-15.
2. Vuillaume M. Reduced oxygen species, mutation, induction and cancer initiation. Mutat Res 1987; 186: 43-72.
3. Meneghini R. Genotoxicity of active oxygen species in mammalian cells. Mutat Res 1988; 195: 215-230.
4. Halliwell B, Gutteridge JMC. Lipid peroxidation, oxygen radicals, cell damage and antioxidant therapy. Lancet 1984; 23: 1396-1397.
5. Hochstein P, Atallah AS. The nature of oxidants and antioxidant systems in the inhibition of mutation and cancer. Mutat Res 1988; 202: 363-375.
6. Subramoniam A, Evans DA, Rajasakhran SP. Hepatoprotective activity of Trichopus zeylanicus extracts against paracetamol induced damage in rats. Ind J Expt Biol 1998; 36: 385-389.
7. Kirtikar KR, Basu BD. Indian Medicinal Plants, Allahabad, Lalit Mohan Basu Publications, 1998, pp 1590-1592.
8. Chatterjee A, Pakrashi SC. The Treatise on Indian Medicinal Plants, New Delhi, Publications and information Directorate, 1995, pp 110-112.
9. Nadkarni KM. The Indian Materia Medica, Bombay, Bombay Popular Prakashan, 1982, p 674.
10. Fraschini F, Demartini G, Esposti D. Pharmacology of Silymarin. Clin Drug Inv 2002; 22: 51-65.
11. Hiroshini A, Toshiharu H, Masahiro H, Sholi. An alteration in liver microsomal membrane of the rat following paracetamol overdose. J Pharm Pharmacol 1987; 39: 1047-1049.
12. VeereshwarayyaV, Thiruvengadam D. Hepatoprotective effect of allicin on tissue defense system in galactosamine/endotoxin challenged rats. J Ethno Pharmacol 2004; 90: 151-154.
13. Retimen S, Frankel SA. Colorimetric method for determination of serum glutamic oxaloacetic and glutamic pyruvate transaminases. Am J Clin Pathol 1957; 28: 56-63.
14. King EJ, Armstrong AR. A convenient method for determining of Serum and bile phosphatase activity. J Canad. Med. Assoc 1934; 31: 376-381.
15. Malloy HT, Evelyn KA. The determination of bilirubin with the photometric colorimeter. J Biol Chem 1937; 119: 481-490.
16. Gornall AG, Bardwill CJ, David MM. Determination of serum proteins by means of the biuret reaction. J Biol Chem 1949; 177: 751-756.
17. Ohkawa H, Onishi N, Yagi K. Assay for lipid peroxidation in animal tissue by thiobarbituric acid reaction. Anal Biochem 1979; 95: 351-358.
18. Ellman GL. Tissue sulphydryl groups. Arch Biochem Biophys 1959; 82: 70-77.
19. Kakkar P, Das B, Viswanathan PN. A modified spectrophotometric assay of superoxide dismutase. Ind J Biochem Biophys 1984; 21: 131 -132.
20. Aebi H. Catalase. In: Bergmeyar (eds). Methods in enzymatic analysis, New York, Academic Press, 1974, pp 674-684.
21. Tirmenstein MA, Nelson SP. Sub cellular binding and effects on calcium homeostasis produced by acetaminophen and a non-hepatotoxic regioisomer 3-hydroxyacetanilide in mouse liver. J Biol Chem 1989; 264: 9814-9819.
22. Vermeulen NPE, Bessems JGM, Van DE, Straat R. Molecular aspects of paracetamol-induced hepatotoxicity and its mechanism based prevention. Drug Metab Rev 1992; 24: 367-407.
23. Vaishwanar I, Kowale CN. Effect of two ayurvedic drugs Shilajeet and Eclinol on changes in liver and serum lipids produced by carbontetrachloride. Ind J Exp Biol 1976; 14: 58-61.
24. Sallie R, Tredger JM, Willaiam. Drugs and the liver. Biopharm Drug Dispos 1999; 12: 251-259.
25. Moss DW, Butterworth PJ. Enzymology and Medicine, London, Pitman Medical, 1974, p139.
26. Prakash J, Gupta SK, Kochupillai V, Singh N, Gupta YK, Joshi S. Chemopreventive activity of Withania somnifera in experimentally induced fibrosarcoma tumo-urs in swiss albino mice. Phytother Res 2001; 15: 240-244.
27. Scott MD, Lubin BH, Zuo L, Kuypers FA. Erythrocyte defense against hydrogen peroxide: Preeminent importance of Catalase. J Lab Clin Med 1991; 118: 7-16.
28. Chance B, Green Stein DS, Roughton RJW. The mechanism of catalase action I-steady state analysis. Arch Biochem Biophys 1952; 37: 301 - 339.

Copyright 2007. Pharmacotherapy Group, Faculty of Pharmacy, University of Benin, Benin City, Nigeria.

The following images related to this document are available:

Photo images